Abstract
Heart failure (HF) is a potentially life-threatening complication of treatment for childhood cancer. We evaluated the risk and risk factors for HF in a large European study of long-term survivors. Little is known of the effects of low doses of treatment, which is needed to improve current treatment protocols and surveillance guidelines.
Lingua originale | Inglese |
---|---|
pagine (da-a) | 96-106 |
Numero di pagine | 11 |
Rivista | Journal of Clinical Oncology |
Volume | 41 |
Numero di pubblicazione | 1 |
DOI | |
Stato di pubblicazione | Pubblicato - 2023 |